Synovial fluid and plasma n3 long chain polyunsaturated fatty acids in patients with inflammatory arthritis
- 1 June 2015
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 97, 7-12
Abstract
No abstract availableKeywords
Funding Information
- Arthritis Australia
- Royal Adelaide Hospital Research Fund
This publication has 36 references indexed in Scilit:
- Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammationJournal of Lipid Research, 2014
- Determinants of Erythrocyte Omega‐3 Fatty Acid Content in Response to Fish Oil Supplementation: A Dose–Response Randomized Controlled TrialJournal of the American Heart Association, 2013
- Resolvins D1, D2, and Other Mediators of Self-Limited Resolution of Inflammation in Human Blood following n-3 Fatty Acid SupplementationClinical Chemistry, 2012
- Fish oil and rheumatoid arthritis: past, present and futureProceedings of the Nutrition Society, 2010
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- Fish oil: what the prescriber needs to knowArthritis Research & Therapy, 2006
- Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n−3 fatty acidsThe American Journal of Clinical Nutrition, 2003
- Dietary intakes and food sources of omega‐6 and omega‐3 polyunsaturated fatty acidsLipids, 2003
- Biochemical effects of a diet containing foods enriched with n−3 fatty acidsThe American Journal of Clinical Nutrition, 2000
- Dietary polyunsaturated fatty acids and inflammatory mediator productionThe American Journal of Clinical Nutrition, 2000